COVID-19 Implication by Physical Interaction of Artificial fog on Respiratory Aerosols

M. Shum
{"title":"COVID-19 Implication by Physical Interaction of Artificial fog on Respiratory Aerosols","authors":"M. Shum","doi":"10.23880/act-16000216","DOIUrl":null,"url":null,"abstract":"Background: Artificial fog consists of small liquid aerosols suspended in air which reduce visibility and reflect light. Artificial fog is used in the film, television, and live entertainment industries to enhance lighting, as a visual effect, and to create a specific sense of mood or atmosphere. Objective: This study investigated the suspension time for liquid respiratory aerosols spiked with tagged deoxyribonucleic acid (DNA) tracers in the presence and absence of glycerin- or glycol-containing artificial fogs. Methods: Liquid respiratory aerosols with tagged DNA tracers were sprayed into a closed environment without and with glycerin- or glycol-containing artificial fog, with air samples taken at regular intervals to determine the decay of tagged DNA tracer over time. The study treatments included Control (no fog), Glycerin Low (~3 mg/m3 ), Glycerin High (~15 mg/m3 ), Glycol Low (~5 mg/m3 ), and Glycol High (~40 mg/m3 ). Results: All artificial fog treatments had lower mean log reduction curves compared to the Control treatment. The differences in mean log reduction for artificial fog treatments vs. control treatments were all statistically significant (p<0.001), except for Glycerin Low treatment (p=0.087). The differences in mean log reduction between treatments using glycerin fog (p=0.129) and glycol fog (p=0.209) were not statistically significant. Conclusion: Artificial fog use does not increase suspension time of liquid respiratory aerosols, and therefore does not appear to increase the risk of airborne transmission of diseases from liquid respiratory aerosols, such as COVID-19. The suspension time of aerosols in glycol-containing artificial fog decreased more than glycerin-containing fog. In practice, the additional reduction in suspension time provided by the physical interaction of liquid respiratory aerosols with artificial fog does not suggest any practical benefit for using artificial fog as a control measure.","PeriodicalId":134434,"journal":{"name":"Advances in Clinical Toxicology","volume":"63 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/act-16000216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Artificial fog consists of small liquid aerosols suspended in air which reduce visibility and reflect light. Artificial fog is used in the film, television, and live entertainment industries to enhance lighting, as a visual effect, and to create a specific sense of mood or atmosphere. Objective: This study investigated the suspension time for liquid respiratory aerosols spiked with tagged deoxyribonucleic acid (DNA) tracers in the presence and absence of glycerin- or glycol-containing artificial fogs. Methods: Liquid respiratory aerosols with tagged DNA tracers were sprayed into a closed environment without and with glycerin- or glycol-containing artificial fog, with air samples taken at regular intervals to determine the decay of tagged DNA tracer over time. The study treatments included Control (no fog), Glycerin Low (~3 mg/m3 ), Glycerin High (~15 mg/m3 ), Glycol Low (~5 mg/m3 ), and Glycol High (~40 mg/m3 ). Results: All artificial fog treatments had lower mean log reduction curves compared to the Control treatment. The differences in mean log reduction for artificial fog treatments vs. control treatments were all statistically significant (p<0.001), except for Glycerin Low treatment (p=0.087). The differences in mean log reduction between treatments using glycerin fog (p=0.129) and glycol fog (p=0.209) were not statistically significant. Conclusion: Artificial fog use does not increase suspension time of liquid respiratory aerosols, and therefore does not appear to increase the risk of airborne transmission of diseases from liquid respiratory aerosols, such as COVID-19. The suspension time of aerosols in glycol-containing artificial fog decreased more than glycerin-containing fog. In practice, the additional reduction in suspension time provided by the physical interaction of liquid respiratory aerosols with artificial fog does not suggest any practical benefit for using artificial fog as a control measure.
人工雾对呼吸道气溶胶的物理相互作用对COVID-19的影响
背景:人造雾由悬浮在空气中的小液体气溶胶组成,它会降低能见度并反射光线。人造雾用于电影,电视和现场娱乐行业,以增强照明,作为视觉效果,并创造特定的情绪或氛围感。目的:研究在含甘油或不含乙二醇的人工雾剂存在和不存在的情况下,加有标记脱氧核糖核酸(DNA)示踪剂的液体呼吸气雾剂的悬浮时间。方法:将带有标记的DNA示踪剂的液体呼吸性气溶胶喷洒到不含甘油或含乙二醇人工雾的封闭环境中,并定期采集空气样本,以测定标记的DNA示踪剂随时间的衰减。研究处理包括对照(无雾)、低甘油(~ 3mg /m3)、高甘油(~ 15mg /m3)、低乙二醇(~ 5mg /m3)和高乙二醇(~ 40mg /m3)。结果:与对照组相比,所有人工雾处理的平均对数减少曲线都较低。除低甘油治疗(p=0.087)外,人工雾治疗与对照治疗的平均对数降低差异均有统计学意义(p<0.001)。甘油雾治疗组(p=0.129)和乙二醇雾治疗组(p=0.209)的平均对数减少量差异无统计学意义。结论:人工雾的使用不会增加液体呼吸道气溶胶的悬浮时间,因此不会增加液体呼吸道气溶胶传播疾病的风险,例如COVID-19。气溶胶在含甘油人工雾中的悬浮时间比含甘油人工雾的悬浮时间缩短。在实践中,液体呼吸气溶胶与人工雾的物理相互作用所提供的悬浮时间的额外减少并不表明使用人工雾作为控制措施有任何实际好处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信